LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | GSK1904529A | 0.12 | uM | LJP6 | 1 | H23 | 72 | hr | 1311 | 4298 | 4870 | 0.8825 | 0.8722 |
MDA-MB-231 | GSK1904529A | 0.12 | uM | LJP6 | 2 | H23 | 72 | hr | 1311 | 4417 | 4961 | 0.8902 | 0.8824 |
MDA-MB-231 | GSK1904529A | 0.12 | uM | LJP6 | 3 | H23 | 72 | hr | 1311 | 4627 | 4973 | 0.9303 | 0.9262 |
MDA-MB-231 | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 1311 | 4402 | 4870 | 0.9039 | 0.8960 |
MDA-MB-231 | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 1311 | 4116 | 4961 | 0.8296 | 0.8145 |
MDA-MB-231 | GSK1904529A | 0.37 | uM | LJP6 | 3 | H22 | 72 | hr | 1311 | 4765 | 4973 | 0.9580 | 0.9559 |
MDA-MB-231 | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 1311 | 4452 | 4870 | 0.9141 | 0.9073 |
MDA-MB-231 | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 1311 | 4299 | 4961 | 0.8665 | 0.8561 |
MDA-MB-231 | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 1311 | 4716 | 4973 | 0.9482 | 0.9454 |
MDA-MB-231 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1311 | 4706 | 4870 | 0.9663 | 0.9641 |
MDA-MB-231 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1311 | 4685 | 4961 | 0.9442 | 0.9411 |
MDA-MB-231 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1311 | 4934 | 4973 | 0.9920 | 0.9917 |
MDA-MB-231 | GSK1904529A | 10 | uM | LJP6 | 1 | H19 | 72 | hr | 1311 | 4547 | 4870 | 0.9336 | 0.9287 |
MDA-MB-231 | GSK1904529A | 10 | uM | LJP6 | 2 | H19 | 72 | hr | 1311 | 4777 | 4961 | 0.9628 | 0.9609 |
MDA-MB-231 | GSK1904529A | 10 | uM | LJP6 | 3 | H19 | 72 | hr | 1311 | 4270 | 4973 | 0.8585 | 0.8475 |
MDA-MB-231 | Linsitinib | 0.04 | uM | LJP5 | 1 | O24 | 72 | hr | 1311 | 4515 | 5128 | 0.8804 | 0.8746 |
MDA-MB-231 | Linsitinib | 0.04 | uM | LJP5 | 2 | O24 | 72 | hr | 1311 | 4001 | 5100 | 0.7845 | 0.7670 |
MDA-MB-231 | Linsitinib | 0.04 | uM | LJP5 | 3 | O24 | 72 | hr | 1311 | 4421 | 5010 | 0.8823 | 0.8746 |
MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 1311 | 4758 | 5128 | 0.9278 | 0.9252 |
MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 1311 | 4648 | 5100 | 0.9114 | 0.9075 |
MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 1311 | 4655 | 5010 | 0.9290 | 0.9252 |
MDA-MB-231 | Linsitinib | 0.37 | uM | LJP5 | 1 | O22 | 72 | hr | 1311 | 4814 | 5128 | 0.9387 | 0.9367 |
MDA-MB-231 | Linsitinib | 0.37 | uM | LJP5 | 2 | O22 | 72 | hr | 1311 | 4853 | 5100 | 0.9516 | 0.9500 |
MDA-MB-231 | Linsitinib | 0.37 | uM | LJP5 | 3 | O22 | 72 | hr | 1311 | 4925 | 5010 | 0.9829 | 0.9822 |
MDA-MB-231 | Linsitinib | 1.11 | uM | LJP5 | 1 | O21 | 72 | hr | 1311 | 4788 | 5128 | 0.9336 | 0.9314 |